Gene Writing - GeneOnline News

Tessera Raises $230M to Develop ‘Gene Writing’ into Novel Genetic Therapy

2021-01-152021-01-15 - by GeneOnline - Leave a Comment

Tessera Therapeutics, a Boston-based life science startup raised $230M in Series B financing. Incubated at Flagship Labs since 2018, Tessera debuted in 2020 with a $50M investment to innovate …

North America

Tessera Therapeutics Aims to Rewrite DNA with New Age Gene Manipulators

2020-07-09 - by GeneOnline - Leave a Comment

By Ruchi Jhonsa, Ph.D. Mobile genetic elements (MGEs) first discovered by Barbara McClintock in 1931 were considered junk and was later found to have functional significance. These DNA pieces famously …